novel biomarker-guided treatment: psma, par, hdacs, etc.
Published 7 years ago • 169 plays • Length 36:44Download video MP4
Download video MP3
Similar videos
-
17:40
when to biopsy: the role for psa and novel biomarkers
-
1:37
recent advances in mhspc: 177lu-psma-617, propel and biomarker-directed strategies
-
1:06:18
biomarker-guided neoadjuvant therapy for bladder cancer
-
12:41
psma: current state of the art and future vision
-
12:17
psma pet imaging in advanced prostate cancer
-
44:25
using hdac inhibitors to improve cancer immunotherapy
-
6:32
avoid prostate biopsies with new cancer screening
-
1:20:03
webinar on liquid biopsy for cancer diagnostics & therapeutic monitoring
-
14:15
overview of treatment for advanced prostate cancer, including metastatic disease - novel treatment
-
12:46
clinical update on psma diagnostics and therapies
-
9:37
psma pet imaging: a primer for the urologist or oncologist
-
11:49
updates in prostate cancer biomarkers
-
1:49
biomarkers made simple
-
11:03
biomarkers for prostate cancer: whom to treat
-
9:58
molecular imaging for prostate cancer
-
12:13
biomarkers’ integration with clinical parameters, imaging, and prognostic instruments
-
17:58
how to integrate psma pet findings into treatment algorithms
-
1:51
ask the expert: which new biomarkers can help guide treatment for prostate cancer?
-
1:24
psa limitations in prostate cancer: advancing treatment de-escalation with imaging biomarkers
-
10:04
there is a role for biomarkers/genomics in the risk stratification of prostate cancer